Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keensight Capital is a leading European growth buyout and private equity investor with deep expertise in the technology and healthcare sectors. The firm partners with management teams of fast-growing, profitable companies—typically generating €10 million to €400 million in revenue—providing capital, strategic guidance, and operational support. With over €5.5 billion in assets under management as of December 2024, Keensight has invested in more than 69 companies across Europe and maintains an average annual portfolio revenue growth rate of approximately 18–20% over the past five years[2][3][8]. The firm is recognized for its responsible investment approach integrating ESG principles into all decisions[1].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keensight Capital.